Sinopharm Group CSIMC Shenzhen Co., Ltd.

The company is affiliated with China Scientific Instruments & Materials Corporation (CSIMC), which is directly under China National Pharmaceutical Group Corporation (SINOPHARM), a leading pharmaceutical and healthcare industry group in China. It is a core enterprise in the group's scientific instruments and medical devices sector. The company was established in June 1962 and has made positive contributions to the development of China's science and technology and health undertakings since its inception. According to the "Twelfth Five-Year" development strategy and plan of Sinopharm Group, Sinopharm CSIMC is striving to build a full industry chain integrating trade, industry, and science in the medical device industry, becoming a comprehensive medical device service platform with brand influence and international competitiveness. Currently, its subsidiaries include China National Medical Device Co., Ltd. (Sinopharm Medical Devices), and it holds shares in GE Hangwei Medical Systems Co., Ltd. and other enterprises. The company is currently a leading medical device commercial enterprise in China, with a leading medical device commercial network in China, and has initially formed a nationwide marketing network layout.
Sinopharm CSIMC Shenzhen Company has always adhered to the purpose of providing specialized, integrated, and comprehensive services to a wide range of users including government agencies, medical and health institutions, research institutes, universities and colleges, and industrial and mining enterprises, and has introduced and sold a large number of advanced technologies and key instruments and equipment for users in the region and across the country. Today, it has developed into a sizable and well-reputed importer and exporter and supplier of instruments, equipment, and medical devices in South China. The company has now reorganized and integrated relevant resources, focusing on developing medical device distribution and delivery business and will assume the function of national medical device reserves in the future.
The company's current and upcoming businesses include: import and export trade and domestic sales of scientific instruments and equipment, medical devices, in vitro diagnostic reagents, electromechanical equipment, and flax textile raw materials; comprehensive integrated bidding for scientific instruments and equipment and medical devices; entrusted procurement services for medical consumables; logistics and distribution; distribution and direct sales; bidding business; technical exchange and services.
Sinopharm CSIMC Shenzhen Company will rely on the overall strategic layout of Sinopharm Group and Sinopharm CSIMC, adhere to Sinopharm Group's corporate philosophy of "Care for Life, Protect Health," follow the corporate spirit of "Responsibility, Professionalism, Integrity, Win-Win," make continuous efforts, actively forge ahead, and strive to develop the company into a large and influential medical device and scientific instrument company in the region, seize the opportunity for integration in the medical device circulation industry, promote industry through trade and science through trade, achieve leapfrog development, and make due contributions to the development of medical and health undertakings in the region and to the development of Sinopharm CSIMC.